Caribou Biosciences, Inc.
CRBU
$1.85
-$0.06-3.14%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 79.30% | -17.59% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 79.30% | -17.59% | |||
| Cost of Revenue | 6.31% | 1,625.81% | |||
| Gross Profit | 1.63% | -1,575.75% | |||
| SG&A Expenses | -6.72% | -11.59% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.52% | -17.05% | |||
| Operating Income | 3.22% | 17.01% | |||
| Income Before Tax | 1.85% | 49.08% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.85% | 49.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.85% | 49.08% | |||
| EBIT | 3.22% | 17.01% | |||
| EBITDA | 3.47% | 16.03% | |||
| EPS Basic | 5.11% | 49.22% | |||
| Normalized Basic EPS | 3.14% | 34.49% | |||
| EPS Diluted | 5.11% | 49.22% | |||
| Normalized Diluted EPS | 3.14% | 34.49% | |||
| Average Basic Shares Outstanding | 1.33% | 0.28% | |||
| Average Diluted Shares Outstanding | 1.33% | 0.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||